Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

Item
http://www.wikidata.org/entity/Q33644850
Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.Oral cyclosporine treatment in dogs: a review of the literature.Preparation and evaluation of cyclosporin A-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method.Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility.Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltOral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice.Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies.Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterineEnhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies.Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study.Applications of nanoparticles in the detection and treatment of kidney diseasesEngineered nanoparticulate drug delivery systems: the next frontier for oral administration?Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems.
P2860

Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

Item
http://www.wikidata.org/entity/Q33644850
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacokinetics and enhanced ...... oxamer 407 cubic nanoparticles
@ast
Pharmacokinetics and enhanced ...... oxamer 407 cubic nanoparticles
@en
type
label
Pharmacokinetics and enhanced ...... oxamer 407 cubic nanoparticles
@ast
Pharmacokinetics and enhanced ...... oxamer 407 cubic nanoparticles
@en
prefLabel
Pharmacokinetics and enhanced ...... oxamer 407 cubic nanoparticles
@ast
Pharmacokinetics and enhanced ...... oxamer 407 cubic nanoparticles
@en
P1433
P1476
P2093
P2860
P304
P31
P407
P478
P577
P698
P932
P1433
P1476
Pharmacokinetics and enhanced ...... oxamer 407 cubic nanoparticles
@en
P2093
P2860
P304
P31
P407
P478
P577
P698
P932